Differential involvement of mu-opioid receptor subtypes in endomorphin-1- and -2-induced antinociception.
Differential involvement of mu-opioid receptor subtypes in endomorphin-1- and -2-induced antinociception.
复制标题
DOI:
10.1016/s0014-2999(99)00181-8
复制
发表时间:
1999-05
影响因子:
5
通讯作者:
S. Sakurada;J. Zadina;A. Kastin;S. Katsuyama;Tsutomu Fujimura;Kimie Murayama;Masayuki Yuki;Hiroshi Ueda;T. Sakurada
中科院分区:
文献类型:
--
作者:
S. Sakurada;J. Zadina;A. Kastin;S. Katsuyama;Tsutomu Fujimura;Kimie Murayama;Masayuki Yuki;Hiroshi Ueda;T. Sakurada
We investigated the role of μ-opioid receptor subtypes in both endomorphin-1 and endomorphin-2 induced antinociception in mice using supraspinally mediated behavior. With tail pressure as a mechanical noxious stimulus, both intracerebroventricularly (i.c.v.) and intrathecally (i.t.) injected-endomorphins produced potent and significant antinociceptive activity. Antinociception induced by i.t. and i.c.v. injection of endomorphin-1 was not reversed by pretreatment with a selective μ1-opioid receptor antagonist, naloxonazine (35 mg/kg, s.c.). By contrast, antinociception induced by i.t. and i.c.v. endomorphin-2 was significantly decreased by μ1-opioid receptor antagonist. Antinociception of both i.t. and i.c.v. endomorphin-1 and -2 was completely reversed by pretreatment with β-funaltrexamine (40 mg/kg, s.c.). The results indicate that endomorphins may produce antinociception through the distinct μ1and μ2subtypes of μ-opioid receptor.